SCHEMBL18852833

SCHEMBL18852833

c1ccc2cc3c(cc2c1)oc1c(-n2c4ccccc4c4ccccc42)nc(-n2c4ccccc4c4ccccc42)nc13

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 3/20 0.36
▸ CREBBP Q92793 1/20 0.36
▸ TSHR P16473 7/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ LMNA P02545 4/20 0.33
▸ HRH4 Q9H3N8 3/20 0.33
▸ MEN1 O00255 3/20 0.33
▸ KMT2A Q03164 3/20 0.33
▸ KDM4E B2RXH2 3/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ MAPT P10636 5/20 0.33
▸ HPGD P15428 1/20 0.33
▸ NPSR1 Q6W5P4 3/20 0.32
▸ NPY1R P25929 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ NPY2R P49146 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ PRKDC P78527 3/20 0.32
▸ USP2 O75604 1/20 0.32
▸ NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26741774 0.91 CREBBP (0.31) HSD17B10CREBBPL3MBTL1
SCHEMBL16905906 0.86 ALDH1A1 (0.46) HSD17B10CREBBPTSHRALDH1A1LMNA
SCHEMBL20024406 0.85 HSD17B10 (0.37) HSD17B10CREBBPTSHRALDH1A1LMNA
SCHEMBL25147239 0.84 KDM4E (0.42) HSD17B10CREBBPTSHRALDH1A1LMNA
SCHEMBL25147259 0.84 KDM4E (0.42) HSD17B10CREBBPTSHRALDH1A1LMNA
SCHEMBL18852827 0.82 TDP1 (0.35) HSD17B10CREBBPTSHRALDH1A1LMNA
SCHEMBL26741712 0.81 TSHR (0.47) HSD17B10TSHRALDH1A1LMNAMEN1
SCHEMBL26741520 0.81 MAPT (0.34) HSD17B10TSHRALDH1A1LMNAMEN1
SCHEMBL18852825 0.80 KMT2A (0.35) HSD17B10TSHRALDH1A1KMT2AKDM4E
SCHEMBL20030077 0.79 KDM4E (0.39) HSD17B10CREBBPTSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 HSD17B10 1427/4885CREBBP 4221/4885TSHR 4138/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 HSD17B10 1427/4885CREBBP 4221/4885TSHR 4138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback